LGND
NASDAQStockLigand Pharmaceuticals Incorporated
$209.96-11.28 (-5.10%)
52-Week Range
$96.67
$221.24
Key Stats
Market Cap
4.2B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.03
Volume
340.1K
Avg Volume
205.6K
Performance
1M
+18.30%
3M
+16.72%
6M
+33.67%
YTD
+16.37%
1Y
+104.68%
3Y
+228.54%
5Y
+35.53%
Price Chart
ETF Exposure
LGND is held by 121 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| HELX | Franklin Genomic Advancements ETF | 3.71% |
| PJP | Invesco Pharmaceuticals ETF | 3.26% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 2.54% |
| AFSC | abrdn Focused U.S. Small Cap Active ETF | 2.41% |
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 2.24% |
| BBP | Virtus Biotech ETF | 1.71% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 1.30% |
| IHE | iShares U.S. Pharmaceuticals ETF | 1.09% |
| RZG | Invesco S&P SmallCap 600 Pure Growth ETF | 1.02% |
| GSC | Goldman Sachs Small Cap Equity ETF | 0.92% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.89% |
| XSMO | Invesco S&P SmallCap Momentum ETF | 0.83% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.71% |
| SGRW | Harbor Active Small Cap Growth ETF (SGRW) | 0.64% |
| BOUT | Innovator IBD Breakout Opportunities ETF | 0.64% |
| OASC | OneAscent Small Cap Core ETF | 0.63% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 0.54% |
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 0.54% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 0.53% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.50% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 0.48% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.47% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 0.44% |
| ESIX | State Street SPDR S&P SmallCap 600 ESG ETF | 0.44% |
| SQLV | Royce Quant Small-Cap Quality Value ETF | 0.42% |
| USVM | VictoryShares US Small Mid Cap Value Momentum ETF | 0.41% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.39% |
| FPX | First Trust US Equity Opportunities ETF | 0.36% |
| QVMS | Invesco S&P SmallCap 600 QVM Multi-factor ETF | 0.35% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.34% |
| JPSE | JPMorgan Diversified Return U.S. Small Cap Equity ETF | 0.34% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.34% |
| XJR | iShares ESG Select Screened S&P Small-Cap ETF | 0.32% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.32% |
| IJR | iShares Core S&P Small-Cap ETF | 0.28% |
| SPSM | State Street SPDR Portfolio S&P 600 Small Cap ETF | 0.28% |
| IWN | iShares Russell 2000 Value ETF | 0.25% |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 0.24% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.22% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.22% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.22% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.20% |
| SAA | ProShares - Ultra SmallCap600 | 0.20% |
| BKSE | BNY Mellon US Small Cap Core Equity ETF | 0.20% |
| AFSM | First Trust Active Factor Small Cap ETF | 0.20% |
| STXK | Strive Small-Cap ETF | 0.19% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.18% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.16% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.15% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.15% |
Page 1 of 3Next
About LGND ETF Exposure
Ligand Pharmaceuticals Incorporated (LGND) is held by 121 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 4.2B, LGND is a widely held institutional stock. The stock currently trades at $209.96. Investors can gain exposure to LGND through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LGND, sorted by portfolio weight.